LCDActive
Stretta Procedure
L34540
Effective: September 4, 2025
Updated: December 31, 2025
Policy Summary
The Stretta procedure for treatment of gastroesophageal reflux disease (GERD) is considered investigational and is not covered. Coverage is denied because objective physiologic efficacy has not been demonstrated, its mechanism of action is unclear, and there is insufficient long-term safety and efficacy data.
Coverage Criteria Preview
Key requirements from the full policy
"The Stretta procedure is considered investigational and is not covered for treatment of gastroesophageal reflux disease (GERD)."
Sign up to see full coverage criteria, indications, and limitations.